In this proof-of-concept pilot study, we aim to develop and validate a custom 15-gene ctDNA NGS panel for detecting single nucleotide variants and small indels in lung cancer, with primary focus on EGFR mutation analysis in NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.